Hologic (HOLX) Short Interest Ratio & Short Volume $72.27 -0.33 (-0.45%) (As of 05:27 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Hologic Short Interest DataHologic (HOLX) has a short interest of 5.18 million shares, representing 2.32% of the float (the number of shares available for trading by the public). This marks a -15.77% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 1.67 million shares to cover all short positions.Current Short Interest5,180,000 sharesPrevious Short Interest6,150,000 sharesChange Vs. Previous Month-15.77%Dollar Volume Sold Short$381.51 millionShort Interest Ratio2.8 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares226,941,000 sharesFloat Size223,700,000 sharesShort Percent of Float2.32%Today's Trading Volume1,797,523 sharesAverage Trading Volume1,670,416 sharesToday's Volume Vs. Average108% Short Selling Hologic? Sign up to receive the latest short interest report for Hologic and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHOLX Short Interest Over TimeHOLX Days to Cover Over TimeHOLX Percentage of Float Shorted Over Time Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Hologic Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20245,180,000 shares $381.51 million -15.8%2.3%2.8 $73.65 11/30/20246,150,000 shares $488.93 million +34.0%2.8%3.9 $79.50 11/15/20244,590,000 shares $360.77 million -5.4%2.0%3.1 $78.60 10/31/20244,850,000 shares $392.22 million -16.5%2.1%3.3 $80.87 10/15/20245,810,000 shares $474.44 million +5.1%2.5%3.9 $81.66 9/30/20245,530,000 shares $450.47 million +6.8%2.4%3.6 $81.46 Get the Latest News and Ratings for HOLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter. 9/15/20245,180,000 shares $420.36 million -7.7%2.3%3.4 $81.15 8/31/20245,610,000 shares $455.76 million +8.5%2.5%3.7 $81.24 8/15/20245,170,000 shares $416.44 million +10.2%2.3%3.3 $80.55 7/31/20244,690,000 shares $382.75 million +3.8%2.1%3.1 $81.61 7/15/20244,520,000 shares $349.58 million -4.4%2.0%3.2 $77.34 6/30/20244,730,000 shares $351.20 million +1.9%2.1%3.4 $74.25 6/15/20244,640,000 shares $333.11 million -8.7%2.0%3.3 $71.79 5/31/20245,080,000 shares $374.80 million +12.4%2.2%3.4 $73.78 5/15/20244,520,000 shares $338.37 million -1.3%2.0%2.9 $74.86 4/30/20244,580,000 shares $347.03 million +1.3%2.0%2.8 $75.77 4/15/20244,520,000 shares $350.48 million +1.8%2.0%2.5 $77.54 3/31/20244,440,000 shares $346.14 million -4.5%1.9%2.5 $77.96 3/15/20244,650,000 shares $352.98 million -15.0%2.0%2.6 $75.91 2/29/20245,470,000 shares $403.69 million +24.6%2.4%3 $73.80 2/15/20244,390,000 shares $323.98 million -2.2%1.9%2.4 $73.80 1/31/20244,490,000 shares $334.24 million -20.1%1.9%2.3 $74.44 1/15/20245,620,000 shares $408.86 million -12.5%2.4%3 $72.75 12/31/20236,420,000 shares $458.71 million -16.2%2.7%3.4 $71.45 12/15/20237,660,000 shares $543.71 million -17.0%3.2%4.1 $70.98 11/30/20239,230,000 shares $658.10 million +49.4%3.9%5 $71.30 11/15/20236,180,000 shares $445.02 million -13.5%2.6%3.5 $72.01 10/31/20237,140,000 shares $472.45 million +3.8%3.0%4.1 $66.17 10/15/20236,880,000 shares $474.58 million +18.8%2.8%3.9 $68.98 9/30/20235,790,000 shares $401.83 million +6.0%2.4%3.2 $69.40 9/15/20235,460,000 shares $392.08 million +17.2%2.3%3.2 $71.81 8/31/20234,660,000 shares $348.29 million +6.2%1.9%2.6 $74.74 8/15/20234,390,000 shares $328.46 million -17.6%1.8%2.5 $74.82 7/31/20235,330,000 shares $423.31 million -2.6%2.2%3.3 $79.42 7/15/20235,470,000 shares $439.35 million +8.8%2.3%3.6 $80.32 6/30/20235,030,000 shares $407.28 million -13.1%2.1%3.5 $80.97 6/15/20235,790,000 shares $469.22 million +0.7%2.4%4.2 $81.04 5/31/20235,750,000 shares $453.62 million +6.1%2.4%4.3 $78.89 5/15/20235,420,000 shares $446.45 million No Change2.2%4.1 $82.37 10/31/20228,340,000 shares $565.45 million +4.4%3.4%5 $67.80We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 10/15/20227,990,000 shares $499.77 million -3.4%3.2%5 $62.55 9/30/20228,270,000 shares $533.58 million +9.1%3.4%5.2 $64.52 9/15/20227,580,000 shares $512.86 million -3.3%3.1%5 $67.66 8/31/20227,840,000 shares $529.67 million +9.5%3.2%5.1 $67.56 8/15/20227,160,000 shares $526.05 million -11.5%2.9%4.1 $73.47 7/31/20228,090,000 shares $577.46 million +9.5%3.3%4.4 $71.38 7/15/20227,390,000 shares $521.66 million -8.4%3.0%3.8 $70.59 6/30/20228,070,000 shares $559.25 million +1.6%3.3%4 $69.30 6/15/20227,940,000 shares $542.46 million -2.6%3.2%3.9 $68.32 5/31/20228,150,000 shares $613.45 million +18.3%3.3%4.2 $75.27 5/15/20226,890,000 shares $525.57 million +59.5%2.8%3.7 $76.28 4/30/20224,320,000 shares $311.00 million +2.4%1.8%2.5 $71.99 4/15/20224,220,000 shares $322.11 million +16.9%1.7%2.4 $76.33 3/31/20223,610,000 shares $277.32 million -2.7%N/A2.2 $76.82 3/15/20223,710,000 shares $263.26 million +16.3%1.5%2.2 $70.96 2/28/20223,190,000 shares $227.03 million +6.3%1.3%1.9 $71.17 2/15/20223,000,000 shares $211.86 million -2.0%1.2%1.8 $70.62 1/31/20223,060,000 shares $214.93 million -15.5%1.2%1.8 $70.24 1/15/20223,620,000 shares $251.92 million +13.8%N/A2.3 $69.59 12/31/20213,180,000 shares $243.46 million -7.8%1.3%2.1 $76.56 12/15/20213,450,000 shares $266.44 million -17.9%1.4%2.3 $77.23 11/30/20214,200,000 shares $313.87 million +1.5%1.7%2.8 $74.73 11/15/20214,140,000 shares $303.26 million +11.3%1.7%2.8 $73.25 10/29/20213,720,000 shares $272.71 million +0.8%1.5%2.6 $73.31 10/15/20213,690,000 shares $257.08 million -6.1%1.5%2.5 $69.67 9/30/20213,930,000 shares $290.07 million -20.9%1.6%2.4 $73.81 9/15/20214,970,000 shares $385.77 million +13.7%2.0%2.7 $77.62 8/31/20214,370,000 shares $345.89 million -8.2%1.7%2.3 $79.15 8/13/20214,760,000 shares $366.14 million -3.8%1.9%2.2 $76.92 7/30/20214,950,000 shares $371.45 million -19.5%2.0%2.1 $75.04 7/15/20216,150,000 shares $420.48 million -4.8%2.4%2.4 $68.37 6/30/20216,460,000 shares $431.01 million +9.1%2.6%2.5 $66.72 6/15/20215,920,000 shares $369.76 million -0.7%2.3%2.5 $62.46 5/28/20215,960,000 shares $375.84 million +8.4%2.4%2.6 $63.06 5/14/20215,500,000 shares $345.40 million -9.8%2.2%2.4 $62.80 4/30/20216,100,000 shares $404.00 million +22.5%2.4%2.8 $66.23 4/15/20214,980,000 shares $373.55 million +6.0%N/A0 $75.01 3/31/20214,700,000 shares $347.19 million -6.2%1.9%2.4 $73.87 3/15/20215,010,000 shares $354.61 million +4.6%2.0%2.5 $70.78 2/26/20214,790,000 shares $346.60 million +21.3%1.9%2.4 $72.36 2/12/20213,950,000 shares $316.08 million -7.5%1.6%2 $80.02 1/29/20214,270,000 shares $323.58 million +17.0%1.7%2.1 $75.78 1/15/20213,650,000 shares $279.15 million -5.0%1.4%1.9 $76.48 12/31/20203,840,000 shares $275.52 million -19.2%1.5%2 $71.75 12/15/20204,750,000 shares $352.31 million +8.7%1.9%2.5 $74.17 11/30/20204,370,000 shares $303.76 million -16.3%1.7%2.2 $69.51 11/15/20205,220,000 shares $364.04 million +16.5%2.1%2.4 $69.74 10/30/20204,480,000 shares $315.84 million +29.5%1.8%2.1 $70.50 10/15/20203,460,000 shares $230.09 million -7.2%1.4%1.6 $66.50 9/30/20203,730,000 shares $247.93 million +3.6%N/A1.7 $66.47We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 9/15/20203,600,000 shares $219.20 million +22.5%1.4%1.5 $60.89 8/31/20202,940,000 shares $175.58 million -1.3%1.2%1.2 $59.72 8/14/20202,980,000 shares $199.09 million -0.3%1.2%1.3 $66.81 7/31/20202,990,000 shares $208.64 million -29.0%1.2%1.2 $69.78 7/15/20204,210,000 shares $250.20 million -10.2%1.6%1.6 $59.43 6/30/20204,690,000 shares $267.33 million +13.6%1.8%1.7 $57.00 6/15/20204,130,000 shares $216.41 million +20.1%1.6%1.4 $52.40 5/29/20203,440,000 shares $182.32 million -6.3%1.3%1.1 $53.00 5/15/20203,670,000 shares $190.58 million -10.7%1.4%1.1 $51.93 4/30/20204,110,000 shares $205.91 million -6.0%1.6%1.3 $50.10 4/15/20204,370,000 shares $180.61 million +70.0%1.7%1.5 $41.33 3/31/20202,570,000 shares $121.07 million -44.1%1.0%0.9 $47.11 3/13/20204,599,900 shares $189.10 million +36.9%1.8%1.7 $41.11 2/28/20203,360,000 shares $98.72 million -19.4%1.3%1.6 $29.38 2/14/20204,170,000 shares $191.07 million +4.5%1.6%2.1 $45.82 1/31/20203,990,000 shares $193.67 million +9.9%1.5%1.7 $48.54 1/15/20203,630,000 shares $193.95 million -17.1%1.4%1.6 $53.43 12/31/20194,380,000 shares $235.29 million -21.5%1.7%2 $53.72 HOLX Short Interest - Frequently Asked Questions What is Hologic's current short interest? Short interest is the volume of Hologic shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 5,180,000 shares of HOLX short. 2.32% of Hologic's shares are currently sold short. Learn More on Hologic's current short interest. What is a good short interest ratio for Hologic? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOLX shares currently have a short interest ratio of 3.0. Learn More on Hologic's short interest ratio. Which institutional investors are shorting Hologic? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Hologic: Jane Street Group LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Hologic? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.32% of Hologic's floating shares are currently sold short. Is Hologic's short interest increasing or decreasing? Hologic saw a decline in short interest in the month of December. As of December 15th, there was short interest totaling 5,180,000 shares, a decline of 15.8% from the previous total of 6,150,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hologic's float size? Hologic currently has issued a total of 226,941,000 shares. Some of Hologic's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hologic currently has a public float of 223,700,000 shares. How does Hologic's short interest compare to its competitors? 2.32% of Hologic's shares are currently sold short. Here is how the short interest of companies compare to Hologic: Edwards Lifesciences Co. (1.26%), IDEXX Laboratories, Inc. (1.73%), ResMed Inc. (5.32%), DexCom, Inc. (2.39%), STERIS plc (0.99%), Insulet Co. (3.79%), Baxter International Inc. (2.57%), Globus Medical, Inc. (1.75%), Masimo Co. (7.01%), Teleflex Incorporated (1.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Hologic stock? Short selling HOLX is an investing strategy that aims to generate trading profit from Hologic as its price is falling. HOLX shares are trading down $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hologic? A short squeeze for Hologic occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HOLX, which in turn drives the price of the stock up even further. How often is Hologic's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOLX, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies EW Short Interest Data IDXX Short Interest Data RMD Short Interest Data DXCM Short Interest Data STE Short Interest Data PODD Short Interest Data BAX Short Interest Data GMED Short Interest Data MASI Short Interest Data TFX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HOLX) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
